Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CapMan is a leading Nordic private asset management and investment firm with a specialized focus on the healthcare and life sciences sectors. The company operates through several investment strategies, including private equity buyout and growth capital, targeting mid-sized companies across Northern Europe. CapMan's healthcare investment activities encompass medical technology, healthcare services, and biotechnology, providing portfolio companies with the capital and strategic expertise needed for international expansion. Historically, the firm managed dedicated life science funds and continues to be an active player in the Nordic healthcare ecosystem. Headquartered in Helsinki, CapMan is publicly listed on the Nasdaq Helsinki exchange and maintains offices in major Nordic cities and London.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CapMan.